Cumberland Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Cumberland Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-9,850	Closed	-$998K	–	56
2015 Q3	$998K	Buy	9,850 +4,270	+77%	+$508K	0.62%	29
2015 Q2	$692K	Buy	5,580 +880	+19%	+$106K	0.37%	34
2015 Q1	$556K	Buy	4,700 +2,790	+146%	+$315K	0.29%	38
2014 Q4	$195K	Buy	1,910 +860	+82%	+$84K	0.11%	40
2014 Q3	$96K	Buy	+1,050	New	+$91.1K	0.06%	36

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

TFA

Transamerica Financial Advisors St. Petersburg, Florida $1.18B AUM 31.24% 1-Year Est. Return

MFS

MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return

Cumberland Advisors's FBT Position: Q4 2015 in Review

Cumberland Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2015, closing a stake of 9,850 shares — an estimated $998K sold.

Cumberland Advisors first reported a position in FBT in Q3 2014 and held it in 5 quarters. The position peaked at $998K in Q3 2015. 129 funds tracked by Wall St. Rank hold FBT as of Q4 2015.

Cumberland Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2015 after selling out during the quarter.
Cumberland Advisors sold 9,850 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2015, an estimated $998K.
Cumberland Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2014 and held it in 5 quarters.
Cumberland Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $998K in Q3 2015.
129 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2015.

Based on Cumberland Advisors's 13F filing for Q4 2015, filed 20 Jan 2016.